Cinctive Capital Management’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
– Sell
-26,549
Closed -$1.6M – 391
2025
Q1
$1.6M Buy
+26,549
New +$1.71M 0.12% 174
2024
Q2
– Sell
-15,922
Closed -$1.28M – 414
2024
Q1
$1.28M Buy
+15,922
New +$1.42M 0.06% 263
2023
Q3
– Sell
-47,531
Closed -$6.46M – 382
2023
Q2
$6.46M Buy
+47,531
New +$5.8M 0.22% 172
2021
Q4
– Sell
-8,487
Closed -$1.11M – 553
2021
Q3
$1.11M Buy
+8,487
New +$1.11M 0.05% 384
2021
Q2
– Sell
-21,434
Closed -$2.8M – 524
2021
Q1
$2.8M Buy
+21,434
New +$2.58M 0.17% 215

Other funds holding CNMD

Cinctive Capital Management's CNMD Position: Q2 2025 in Review

Cinctive Capital Management sold out of CONMED (CNMD) in Q2 2025, closing a stake of 26,549 shares — an estimated $1.6M sold.

Cinctive Capital Management first reported a position in CNMD in Q1 2021 and held it in 5 quarters. The position peaked at $6.46M in Q2 2023. 277 funds tracked by Wall St. Rank hold CNMD as of Q2 2025.

  • Cinctive Capital Management reported no remaining CONMED position as of Q2 2025 after selling out during the quarter.
  • Cinctive Capital Management sold 26,549 CONMED shares in Q2 2025, an estimated $1.6M.
  • Cinctive Capital Management first reported a position in CONMED in Q1 2021 and held it in 5 quarters.
  • Cinctive Capital Management's CONMED position peaked at $6.46M in Q2 2023.
  • 277 funds tracked by Wall St. Rank held CONMED as of Q2 2025.

Based on Cinctive Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.